3C PATCH® WOUND MANAGEMENT SYSTEM

SAWC SPRING 2022, APRIL 6-10

PHOENIX, ARIZONA

VISIT US AT BOOTH #926

3C Patch is an innovative wound management solution that is 100% autologous and comprises the patient’s living cells – growth factors and immune cells. 

Visit us at booth #926 at SAWC Spring, April 6-10, Phoenix, Arizona.

Innovation Theater

The Patient’s Living Cells Hold the Key to Healing Diabetic Wounds: The Evidence, Implementation, and the New Reimbursement for the 3C Patch

Speakers

William Marston, MD

Professor of Surgery
University of North Carolina School of Medicine
Chapel Hill, NC

James B. McGuire, DPM, LPT, LPed

Professor Clinician Scholar
Temple University School of Podiatric Medicine
Berwyn, PA

Jason M. Mendivil, DPM

Medical Director
PULSE Amputation Prevention Centers
El Paso, TX

INNOVATION THEATER

Join us to learn about 3C Patch, a new personalized treatment option now available for chronic diabetic wounds.

1. Science and Mode of Action
3C Patch has been shown to significantly increase the chances of healing in a large randomized control trial (The Lancet Diabetes & Endocrinology).

2. Clinical workflow
3C Patch is created through a fully automated centrifugation process that requires minimal hands-on time. We will dive into the practical aspects of implementing the 3C Patch in a busy clinic.

3. Clinical evidence
The panel will present patient case reports detailing treatment progress and results obtained using 3C Patch

Date: Saturday, April 9

Time: 10:30 AM – 11:30 AM MST

Location: 227

RESERVE YOUR SEAT

This session is complimentary for registered SAWC Spring 2022 attendees; however, additional registration is required. To add this session to your existing registration: visit the SAWC registration page/select “Get Log in Link”/ “Edit Registration”/navigate through the registration until the “Additional Products” page/add the session to your registration. For questions, please contact registration@hmpglobal.com. Space is limited and available on a first-come, first-served basis.

SIGN-UP TO WATCH THIS SESSION ON DEMAND

If you would like to watch this session online on-demand, please fill out the form below, and we’ll email you a link after the event with the complete recording of this Innovation Theater Session.

CLINICIAN

Dr. Martin Johnson

“The 3C Patch® has been well received by both the patients and the staff. Because you are delivering the patient’s own growth factors and leukocytes, you may consider its use in most chronic wounds.“ Read more…

Dr. Martin Johnson
Plastic Surgeon, Arizona

PATIENT

Philip Herbert patient

“I have been told that I was going to have my foot taken off and because I have a metal plate in my ankle it would have meant amputating at the knee. 3C Patch® is absolutely amazing.” Read more…

Philip Herbert
54-year-old patient, West Yorkshire

WOUND CARE SERVICE LINE DIRECTOR

Frank Aviles
“The automated centrifugation process allows for minimal hands-on time, and the resulting patch is easy to apply. This, combined with the strong clinical evidence, were the main factors in trialing the product.” Read more…
Frank Aviles, PT, CWS, FACCWS, CLT
Natchitoches Regional Medical Center, Louisiana

ONLY THE PATIENT’S LIVING CELLS TO SIGNIFICANTLY INCREASE THE CHANCES OF HEALING1

Clinically proven to heal more diabetic chronic wounds faster 1

3C Patch® is backed by extensive clinical research, including a large (n=269), international, randomized controlled trial published in The Lancet showing that 58% more patients healed with 3C Patch® compared to standard of care, and the time for healing was significantly shorter (p=0.0246).

The 3C Patch® System is FDA cleared and Nationally covered by Medicare.

Diabetic wound treated with 3C Patch

Concentrating the body’s own living cells into heal into a robust 3-layer patch to support wound healing

3C Patch® draws on the body’s capacity to aid its own healing process. Made only from the patient’s own blood – nothing else, the entirely alive cells in 3C Patch® are continuously released. 3-5

3C Patch layers containing living cells

Living cells from the patient’s blood

The 3C Patch® continuously releases the patient’s own living cells – growth factors and immune cells– which can adapt to the wound environment3-5. They are known to give signals and orchestrate the wound healing process over time to get to wound closure.

3C Patch process at SAWC

Remarkably simple and readily available

3C Patch® is created through a completely automated centrifugation process, at the point of care. The 3C Patch® is ready when your patient needs it – the process takes approx. 15-20 min and the patch is placed on the wound immediately.

3C Patch is recommended by IWGDF

The International Working Group on the Diabetic Foot (IWGDF) recommends the use of the 3C Patch®, an autologous combined leukocyte, platelet, and fibrin patch, as an adjunctive treatment for non-infected diabetic foot ulcers that are difficult to heal.

BOOK A MEETING WITH THE REAPPLIX LEADERSHIP TEAM AT SAWC SPRING 2022

We have reserved a private meeting space at SAWC Spring 2022 with the sole focus on learning how we can become a trusted partner for you, your patients, and your wound care clinic.

Rasmus Lundquist

3C Patch Co-Founder & CSO

Cory West

VP Marketing and Strategy

Daniel Andrews

VP Healthcare Systems & Training

References

1. Game F., Jeffcoate W., Tarnow L., Jacobsen JL., Whitham DJ., Harrison EF., Ellender SJ., Fitzsimmons D., Löndahl M., LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked randomized controlled trial. Lancet Diabetes Endocrinology. 2018;6(11):870-878.

2. Löndahl, M., Tarnow, L., Karlsmark, T., Lundquist, R., Nielsen, A. M., Michelsen, M., Jørgensen, B. (2015). Use of an autologous leucocyte and platelet rich fibrin patch on hard-to-heal DFUs: a pilot study. Journal of Wound Care, 24(4), 172–8.

3. Lundquist, Jørgensen, Fagher, Löndahl (2015). 3C Patch™ – an adaptive triple layered autologous platelet and leukocyte rich fibrin patch and its clinical use in the treatment of hard-to-heal diabetic foot ulcers. Poster, Innovations in Wound Healing 2015.

4. Schmidt et al. (2019) “An autologous leukocyte and platelet-rich fibrin patch provides immune cells, cytokines and growth factors relevant for treating diabetic foot ulcers” Poster, ISDF 2019, The Hague, NL

5. Lundquist R et al. (2013). Characteristics of an autologous leukocyte and platelet-rich fibrin patch intended for the treatment of recalcitrant wounds. Wound Repair and Regeneration 21(1), 66–76